Multinational specialty bio-pharmaceutical company.
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Re-authorization of the Pandemic and All-Hazards Preparedness Act; NDAA - provisions related to biological and chemical defense; Department of Defense appropriations for Medical Countermeasures; FDA regulatory issues; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, Naloxone access, and co-prescribing/opioid prescribing guidelines.
HCR - Health Issues
134 - Centers For Disease Control & Prevention (CDC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 18 - Office of Management & Budget (OMB) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA)
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
EDWARD C. RENO DERRICK M WHITE JEFFREY SADOSKY JERRY DRISCOLL ZACHARY WILLIAMS WESLEY RYAN WELCH ELIZABETH GREER RICK MURPHY KRISTINA DUNKLIN